AegirBio AB (AegirBio AB) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB ROE % Adjusted to Book Value?

AegirBio AB's ROE % for the quarter that ended in Mar. 2024 was 0.00%. AegirBio AB's PB Ratio for the quarter that ended in Mar. 2024 was N/A. AegirBio AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

AegirBio AB ROE % Adjusted to Book Value Historical Data

The historical data trend for AegirBio AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB ROE % Adjusted to Book Value Chart

AegirBio AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

AegirBio AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial													-	-57.84	-64.13	-	-

Competitive Comparison of AegirBio AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, AegirBio AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AegirBio AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AegirBio AB's ROE % Adjusted to Book Value falls into.

AegirBio AB ROE % Adjusted to Book Value Calculation

AegirBio AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-314.94%	/	N/A
	=	N/A

AegirBio AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

AegirBio AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of AegirBio AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

AegirBio AB (AegirBio AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

AEGIR:Sweden 52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines